1240 Safety profile of pembrolizumab monotherapy versus pembrolizumab with combined treatments: analysis of french pharmacovigilance database
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
_version_ | 1797629785226084352 |
---|---|
author | Laure Thomas Samy Babai Axelle Histe |
author_facet | Laure Thomas Samy Babai Axelle Histe |
author_sort | Laure Thomas |
collection | DOAJ |
first_indexed | 2024-03-11T10:57:54Z |
format | Article |
id | doaj.art-156bcaef0daa4311b345e1ed16d3fe78 |
institution | Directory Open Access Journal |
issn | 2051-1426 |
language | English |
last_indexed | 2024-03-11T10:57:54Z |
publishDate | 2023-11-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | Journal for ImmunoTherapy of Cancer |
spelling | doaj.art-156bcaef0daa4311b345e1ed16d3fe782023-11-12T23:55:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.12401240 Safety profile of pembrolizumab monotherapy versus pembrolizumab with combined treatments: analysis of french pharmacovigilance databaseLaure Thomas0Samy Babai1Axelle Histe24 Regional Pharmacovigilance Center, Henri Mondor Hospital, Créteil, FranceMondor Hospital, Creteil, FranceMondor Hospital, Creteil, France |
spellingShingle | Laure Thomas Samy Babai Axelle Histe 1240 Safety profile of pembrolizumab monotherapy versus pembrolizumab with combined treatments: analysis of french pharmacovigilance database Journal for ImmunoTherapy of Cancer |
title | 1240 Safety profile of pembrolizumab monotherapy versus pembrolizumab with combined treatments: analysis of french pharmacovigilance database |
title_full | 1240 Safety profile of pembrolizumab monotherapy versus pembrolizumab with combined treatments: analysis of french pharmacovigilance database |
title_fullStr | 1240 Safety profile of pembrolizumab monotherapy versus pembrolizumab with combined treatments: analysis of french pharmacovigilance database |
title_full_unstemmed | 1240 Safety profile of pembrolizumab monotherapy versus pembrolizumab with combined treatments: analysis of french pharmacovigilance database |
title_short | 1240 Safety profile of pembrolizumab monotherapy versus pembrolizumab with combined treatments: analysis of french pharmacovigilance database |
title_sort | 1240 safety profile of pembrolizumab monotherapy versus pembrolizumab with combined treatments analysis of french pharmacovigilance database |
work_keys_str_mv | AT laurethomas 1240safetyprofileofpembrolizumabmonotherapyversuspembrolizumabwithcombinedtreatmentsanalysisoffrenchpharmacovigilancedatabase AT samybabai 1240safetyprofileofpembrolizumabmonotherapyversuspembrolizumabwithcombinedtreatmentsanalysisoffrenchpharmacovigilancedatabase AT axellehiste 1240safetyprofileofpembrolizumabmonotherapyversuspembrolizumabwithcombinedtreatmentsanalysisoffrenchpharmacovigilancedatabase |